PMX464
PMX464 (AW 464), a thiol-reactive quinol, is the inhibitor of thioredoxin-thioredoxin reductase (Trx/TrxR) system. PMX464 can inhibit NF-κB-mediated proinflammatory activation of human type II alveolar epithelial cells.
For research use only. We do not sell to patients.
- CAS No.: 485842-97-5
- Formula: C13H9NO2S
- Molecular Weight:243.28
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
0.5 μM
Compound: 1
|
Growth inhibition of human A549 cells after 72 hrs by MTT assay
Growth inhibition of human A549 cells after 72 hrs by MTT assay
|
[PMID: 17343370] |
| A549 | IC50 |
2.35 μM
Compound: 7a
|
Inhibitory activity against A549 lung adenocarcinoma cell line
Inhibitory activity against A549 lung adenocarcinoma cell line
|
[PMID: 12570375] |
| HCT-116 | GI50 |
0.11 μM
Compound: PMX 464
|
Antitumor activity against human HCT116 cells by MTT assay
Antitumor activity against human HCT116 cells by MTT assay
|
[PMID: 16908135] |
| HCT-116 | IC50 |
0.03 μM
Compound: 1
|
Growth inhibition of human HCT116 cells after 72 hrs by MTT assay
Growth inhibition of human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 17343370] |
| HCT-116 | IC50 |
0.04 μM
Compound: 7a
|
Inhibitory activity against HCT116 colon cancer cell line
Inhibitory activity against HCT116 colon cancer cell line
|
[PMID: 12570375] |
| HT-29 | GI50 |
0.59 μM
Compound: PMX 464
|
Antitumor activity against human HT29 cells by MTT assay
Antitumor activity against human HT29 cells by MTT assay
|
[PMID: 16908135] |
| HT-29 | IC50 |
0.38 μM
Compound: 7a
|
Inhibitory activity against HT-29 colon cancer cell line
Inhibitory activity against HT-29 colon cancer cell line
|
[PMID: 12570375] |
| MCF7 | GI50 |
0.44 μM
Compound: PMX 464
|
Antitumor activity against human MCF7 cells by MTT assay
Antitumor activity against human MCF7 cells by MTT assay
|
[PMID: 16908135] |
| MCF7 | IC50 |
0.35 μM
Compound: 7a
|
Inhibitory activity against MCF-7 mammary carcinoma cell line
Inhibitory activity against MCF-7 mammary carcinoma cell line
|
[PMID: 12570375] |
| MDA-MB-468 | GI50 |
0.41 μM
Compound: PMX 464
|
Antitumor activity against human MDA-MB-468 cells by MTT assay
Antitumor activity against human MDA-MB-468 cells by MTT assay
|
[PMID: 16908135] |
| MDA-MB-468 | IC50 |
0.79 μM
Compound: 7a
|
Inhibitory activity against MDA-468 mammary carcinoma cell line
Inhibitory activity against MDA-468 mammary carcinoma cell line
|
[PMID: 12570375] |
| MRC5 | EC50 |
0.18 μM
Compound: 4, PMX 464
|
Cytotoxicity against human MRC5 cells after 3 days by resazurin-based fluorescence assay
Cytotoxicity against human MRC5 cells after 3 days by resazurin-based fluorescence assay
|
[PMID: 22264753] |
| Panel NCI-60 (60 carcinoma cell lines) | GI50 |
0.23 μM
Compound: 2
|
Mean in vitro GI50 value against 60 human cancer cell line was determined
Mean in vitro GI50 value against 60 human cancer cell line was determined
|
[PMID: 15658878] |
| Panel NCI-60 (60 carcinoma cell lines) | GI50 |
0.23 μM
Compound: PMX 464
|
Antitumor activity against human NCI60 cells
Antitumor activity against human NCI60 cells
|
[PMID: 16908135] |
Chemical Information
-
CAS No. 485842-97-5
-
Molecular Weight 243.28
-
Formula C13H9NO2S
-
SMILES
O=C1C=CC(O)(C2=NC3=CC=CC=C3S2)C=C1
-
Synonyms
AW 464
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)